Drug Trial Radar · NCT07486960
Study to Evaluate Tulisokibart in Adults With Psoriatic Arthritis (MK-7240-015)
Last checked: Nov 20, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
140
Planned (sponsor's estimate)
Start
Apr 20, 2026
Primary completion
Feb 17, 2027
Study completion Jul 18, 2029
Sponsor
- Lead sponsor
- Merck Sharp & Dohme LLCMerck & Co. (MRK)
- Sponsor type
- Industry
- First posted
- Mar 23, 2026
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Researchers are looking for new ways to treat Psoriatic Arthritis (PsA). This study will help find out if a study medicine called tulisokibart (MK-7240) can treat symptoms of active PsA. This study assesses the efficacy, safety, and tolerability of tulisokibart in adult participants with active PsA. In this study, researchers will look at different doses of tulisokibart. Researchers want to learn if at least one of the study doses of tulisokibart works better than a placebo to lessen PsA symptoms. A placebo looks like the study medicine but has no study medicine in it. Using a placebo helps researchers better understand the effects of the study medicine.
Conditions
- Psoriatic Arthritis
Interventions
TulisokibartDrug
Subcutaneous administration
PlaceboDrug
Subcutaneous administration
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Achieving American College of Rheumatology 20% Response Criteria (ACR20) at Week 16Time frame: Week 16
Locations
50 sites in 8 countries. Site status is shown where the registry gives one.
Arizona Arthritis & Rheumatology Associates, P.C. ( Site 5117)
Sun City, Arizona
Arizona Arthritis & Rheumatology Associates, P.C. - Tucson ( Site 5120)
Tucson, Arizona
Medvin Clinical Research - Riverside ( Site 5115)
Riverside, California
Cohen Medical Centers ( Site 5111)
Thousand Oaks, California
Medvin Clinical Research - Tujunga ( Site 5113)
Tujunga, California
Arthritis and Rheumatic Disease Specialties ( Site 5105)
Aventura, Florida
International Center for Research ( Site 5124)
Tampa, Florida
St. Luke's Clinic - Rheumatology - Boise ( Site 5109)
Boise, Idaho
Johns Hopkins University Division of Rheumatology ( Site 5132)
Baltimore, Maryland
Arthritis and Rheumatism Associates - Rockville ( Site 5127)
Rockville, Maryland
Kansas City Physician Partners ( Site 5119)
Kansas City, Missouri
Physician Research Collaboration, LLC ( Site 5102)
Lincoln, Nebraska
Joseph S. and Diane H. Steinberg Ambulatory Care Center ( Site 5106)
Brooklyn, New York
Joint and Muscle Research Institute ( Site 5108)
Charlotte, North Carolina
Altoona Center for Clinical Research ( Site 5110)
Duncansville, Pennsylvania
Perelman Center for Advanced Medicine ( Site 5134)
Philadelphia, Pennsylvania
Articularis Healthcare Group dba: Low Country Rheumatology ( Site 5128)
Summerville, South Carolina
Greater Houston Rheumatology ( Site 5103)
Houston, Texas
Centre Rhumatologie De L'Est ( Site 5201)
Rimouski, Quebec, Canada
Centre de Recherche Musculo-Squelettique ( Site 5202)
Trois-Rivières, Quebec, Canada
Centro de Estudios GyC ( Site 8206)
Santiago, Region M. de Santiago, Chile
Enroll SpA ( Site 8203)
Santiago, Region M. de Santiago, Chile
Clinica Dermacross ( Site 8200)
Santiago, Region M. de Santiago, Chile
CECIM ( Site 8205)
Santiago, Region M. de Santiago, Chile
Bradfordhill ( Site 8212)
Santiago, Region M. de Santiago, Chile
Centro Internacional de Estudios Clinicos (CIEC) ( Site 8201)
Santiago, Region M. de Santiago, Chile
Clinica de la Costa S.A.S. ( Site 8301)
Barranquilla, Atlántico, Colombia
Centro de investigacion en reumatologia y especialidades medicas SAS (CIREEM SAS) ( Site 8306)
Bogota, Cundinamarca, Colombia
Fundación Valle del Lili ( Site 8302)
Cali, Valle del Cauca Department, Colombia
Rheumatologische Schwerpunktpraxis ( Site 6405)
Berlin, Germany
HRF II - Hamburger Rheuma Forschungszentrum II MVZ für Rheumatologie und Autoimmunmedizin Hamburg G ( Site 6404)
Hamburg, Germany
Rheuma-Research Lausitz ( Site 6409)
Cottbus, Brandenburg, Germany
Rheumazentrum Ruhrgebiet ( Site 6400)
Herne, North Rhine-Westphalia, Germany
MICS Centrum Medyczne Bydgoszcz ( Site 6907)
Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
Szpital Uniwersytecki Nr 2 im. dr J. Biziela w Bydgoszczy ( Site 6904)
Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland
MICS Centrum Medyczne Torun ( Site 6903)
Torun, Kuyavian-Pomeranian Voivodeship, Poland
Zespół Poradni Specjalistycznych Reumed Filia nr 1 Wallenroda ( Site 6901)
Lublin, Lubusz Voivodeship, Poland
MICS Centrum Medyczne Warszawa ( Site 6905)
Warsaw, Masovian Voivodeship, Poland
Narodowy Instytut Geriatrii Reumatologii i Rehabilitacji im.Prof. El. Reicher-ul.Spartanska 1 ( Site 6906)
Warsaw, Masovian Voivodeship, Poland
Hospital Vall d' Hebron ( Site 7101)
Barcelona, Spain
Showing 40 of 50 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.